Cover & TOC
Document type
monografie
monografie
Document record
Source: katalogy Medvik
Title
COMIRNATY®, COVID-19 mRNA vaccine : COVID-19 vaccine explainer : 18 January 2021
Author
Date of issue
2021
Publisher
[Geneva] : World Health Organization, 2021
Physical description
6 stran
Language
angličtina
Country
Švýcarsko
Document type
monografie
Link
Call number
NLK: online
Record number
MED00206364
Persistent link
Abstract
COMIRNATY® is a messenger RNA (mRNA) based vaccine against coronavirus disease 2019 (COVID-19). The mRNA instructs the cell to produce proteins of the S antigen (a piece of the spike protein unique to SARS-CoV-2) to stimulate an immune response. Efficacy shown in clinical trials in participants with or without evidence of prior infection with SARS-CoV-2 and who received the full series of vaccine (2 doses) was approximately 95% based on a median follow-up of two months.
Clipboard
Further actions